June 1st, 2022- Brisbane, Australia- Australian life science company, QBiotics will showcase positive efficacy data from its completed phase I trial of lead cancer molecule, tigilanol tiglate, and its Phase II clinical program at Bio 2022, the world’s largest gathering of biot...